Employers urged to delay claims after UIF website reveals confidential information, including bank account details and payroll information
Technical glitches and backlogs have hobbled the government’s flagship programme to cushion the Covid-19 economic shock, resulting in R4.2bn in unpaid claims and denying cash to nearly a million potentially deserving workers who haven’t had an income in three months.
President Cyril Ramaphosa’s team came up with a form of salary protection under which the Unemployment Insurance Fund would pay out between R3,500 and R6,700 for three months until the end of June to workers forfeiting their salaries during the lockdown.A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New study confirms 'cough, fever and fatigue' are the most common Covid-19 symptomsResearchers add that it's likely that a large proportion of people who had the virus did not display symptoms.
Read more »
Pietermaritzburg court closed after staff test positive for Covid-19The Pietermaritzburg magistrate's court has been temporarily closed after two staff members tested positive for Covid-19.
Read more »
Gauteng in the eye of Covid-19 storm as death bell tolls for SAIn the time it takes to read these first few lines, another four people in SA will have been diagnosed with Covid-19 as the disease comes closer to home, cutting a deadly swathe through the country and claiming an average of 70 lives a day.
Read more »
DAILY MAVERICK WEBINAR: ‘Equitable access’ the main concern in race for Covid-19 vaccineIt seems science will succeed, but will politics hinder equitable access to the forthcoming Covid-19 vaccine? Mark Heywood chatted to Professors Shabir Madhi and Helen Rees about South Africa’s first clinical trial for such a vaccine.
Read more »